Colon Cancer Treatment: Surgery, Medicines and Follow-Up Care

Colon cancer treatment can involve surgery, medicines, radiation, or a combination, with choices shaped by where the tumor is, how far it has grown, whether it has spread, and a person’s overall health. The range of options can look wide, but each has a different role. Surgery is central for many localized tumors; medicines that act throughout the body are often used when cancer has spread or to lower the chance that it returns after surgery. The care team can explain how a proposed approach fits the tumor’s features and the person’s priorities.

Surgery for localized tumors

For a small, early tumor or a precancerous polyp, removal during colonoscopy may be possible. A clinician passes a flexible tube with a camera through the anus and uses instruments threaded through it to remove the growth. This is called a polypectomy or local excision. When a tumor is larger or extends deeper into tissue, the surgeon may remove the affected section of colon or rectum, along with a margin of nearby tissue and lymph nodes.

This larger operation is called a colectomy when it removes part of the colon, or a proctectomy when it removes part of the rectum. Surgeons may operate through a larger abdominal incision or use laparoscopy, which involves several smaller incisions and a camera. When possible, the healthy ends of the bowel are joined. If they can’t be reconnected right away, the surgeon may make an opening in the abdomen, called a stoma, so waste can pass into an ostomy pouch. That opening may be temporary while the bowel heals, or permanent.

Surgery carries risks such as bleeding, infection, blood clots, injury to nearby organs, and scar tissue. Two risks specific to bowel surgery are ileus, a temporary slowdown or stoppage in the bowel’s movement of waste, and a leak where the bowel ends have been joined. The surgical team can discuss which risks are relevant to a particular operation and what recovery may involve.

If cancer has spread to limited areas in the liver or lungs, procedures such as ablation may sometimes be considered. These treatments use extreme heat or cold to destroy cancer cells or interrupt their blood supply. Cryosurgery freezes tissue with a probe, while radiofrequency ablation uses high-energy radio waves to heat it. Whether a procedure is suitable depends on the cancer’s location and extent.

Medicines that treat cancer throughout the body

Chemotherapy travels through the body and can be used when colon cancer has spread. It may also be given before surgery to shrink a tumor or afterward to target cancer cells that might remain. Medicines used for colorectal cancer include capecitabine, fluorouracil, irinotecan, oxaliplatin, and the combination of trifluridine and tipiracil. They may be taken by mouth or given through a vein, often in treatment cycles with breaks between them. A course can last several months, depending on the treatment approach.

For cancer that has spread to the liver, chemotherapy may sometimes be delivered into the artery supplying the liver. This route aims treatment at that organ and may reduce some side effects, though the source does not specify when it is appropriate. Because chemotherapy can affect healthy fast-growing cells as well as cancer cells, side effects may include hair loss, mouth sores, fatigue, diarrhea, reduced appetite, skin irritation, and nerve damage. The effects vary among medicines and people.

Targeted medicines are used for some metastatic cancers that can’t be treated with surgery or radiation, often alongside chemotherapy. They act on particular features that help cancer cells grow. Tumor testing for biomarkers, including certain proteins or gene changes, can help show whether a targeted drug may be a match. Examples include medicines that block VEGF, a protein involved in the growth of blood vessels that supply tumors, and medicines that block EGFR, a protein that can promote cancer cell growth.

Other targeted drugs act on specific gene changes or proteins, including BRAF, NTRK, RET, KRAS, and HER2. A multikinase medicine, regorafenib, acts on several growth-signaling pathways and may be used after other treatments have not worked; its use does not depend on a particular biomarker. Side effects vary by drug and can include high blood pressure, bleeding, headaches, skin changes, fatigue, diarrhea, or liver problems. Testing and treatment decisions belong in a discussion with the oncology team, which can explain what a result means for the options available.

Radiation and immunotherapy

Radiation is a routine part of treatment for rectal cancer, but it has a more occasional role in colon cancer, which is commonly treated with surgery and chemotherapy. Radiation may be combined with chemotherapy before surgery to shrink a tumor, or used during or after surgery in selected cases. It may also be considered for people who can’t have surgery or whose cancer has spread. External-beam treatment directs radiation from a machine toward the tumor; internal treatment places radioactive material near or inside it. Side effects can include fatigue, skin irritation, diarrhea, nausea, vomiting, bladder inflammation, and sexual difficulties.

Immunotherapy helps the immune system recognize and attack cancer cells. Some medicines block PD-1 or CTLA-4 proteins on immune cells, which normally limit their activity. Options named for colorectal cancer include atezolizumab, dostarlimab, ipilimumab, nivolumab, and pembrolizumab; delivery is generally by infusion, although one atezolizumab formulation is given under the skin. Whether immunotherapy is suitable depends on the cancer’s characteristics.

Immune treatments can cause the immune system to attack healthy tissue, sometimes leading to serious reactions. An infusion reaction may cause itching, flushing, breathing difficulty, fever, or chills. Other possible effects include dizziness, fatigue, fever, digestive problems, fluid retention, headache, joint pain, and weakness. Research into approaches such as vaccines and CAR T-cell therapy continues, but the source describes these as areas under study rather than established options for every patient.

Support and follow-up

Palliative care can help manage cancer symptoms, treatment side effects, pain, and the emotional strain of living with cancer. It can begin at diagnosis and take place alongside cancer treatment. It is distinct from hospice care, which has a different role in care near the end of life.

Lifestyle changes don’t treat colon cancer, though they may support health after treatment. The source describes a clinical trial in which people who took part in a structured exercise program after surgery and chemotherapy lived longer without cancer progression; it gives no trial size or numerical results, so the finding should not be read as a guarantee for an individual. General measures mentioned include maintaining a healthy weight, eating fruits, vegetables, whole grains, and lean proteins, limiting red and processed meat and added sugar, avoiding alcohol, and stopping smoking.

Cancer can return even after successful treatment. Follow-up is therefore planned for at least five years and may include colonoscopies, blood tests, and imaging. The timing and mix of tests depend on the individual’s care plan. Asking the doctor or pharmacist about the purpose of each treatment, likely side effects, supportive care, and follow-up schedule can help make the next steps clearer.